Literature DB >> 9363034

Cardiovascular risk factors prior to the development of non-insulin-dependent diabetes mellitus in persons with impaired glucose tolerance: the Hoorn Study.

G Nijpels1, C Popp-Snijders, P J Kostense, L M Bouter, R J Heine.   

Abstract

The aim of the study was to analyze cardiovascular risk factors as predictors for developing non-insulin-dependent diabetes mellitus (NIDDM) in people with impaired glucose tolerance. A cross-sectional survey of glucose tolerance was conducted in people, aged 50-74, who were randomly selected from the registry of the middle-sized town Hoorn (The Netherlands). Based on the mean values of two oral glucose tolerance tests, people were classified in glucose tolerance categories according to the WHO criteria. The mean follow-up time was 36 months (range 13-55 months). The cumulative incidence of NIDDM was 34% (95% CI 16.9-45.1). In multiple logistic regression analysis, cardiovascular risk factors at baseline did not predict the conversion from impaired glucose tolerance to NIDDM, in contrast with the two-hour plasma glucose level (odds ratio 3.56, p < 0.001) and the fasting proinsulin level, as one of the determinants of beta-cell dysfunction (Odds ratio 2.1, p < 0.05). The baseline HDL-cholesterol level, one of the components of the insulin resistance syndrome, was associated with the conversion from impaired glucose tolerance to normal glucose tolerance (Odds ratio 1.58, p < 0.05). The results of our study seem to support the hypothesis that conversion from impaired glucose tolerance to normal glucose tolerance depends on insulin resistance and the development of NIDDM from impaired glucose tolerance depends on beta-cell dysfunction.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9363034     DOI: 10.1016/s0895-4356(97)00119-4

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  3 in total

1.  The cost of diabetes Type II in Europe: the CODE-2 Study.

Authors:  M Massi-Benedetti
Journal:  Diabetologia       Date:  2002-05-24       Impact factor: 10.122

2.  Rapamycin induces glucose intolerance in mice by reducing islet mass, insulin content, and insulin sensitivity.

Authors:  Shi-Bing Yang; Hye Young Lee; David Matthew Young; An-Chi Tien; Ashley Rowson-Baldwin; Yu Yu Shu; Yuh Nung Jan; Lily Yeh Jan
Journal:  J Mol Med (Berl)       Date:  2011-11-22       Impact factor: 4.599

3.  Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia.

Authors:  Bernd Richter; Bianca Hemmingsen; Maria-Inti Metzendorf; Yemisi Takwoingi
Journal:  Cochrane Database Syst Rev       Date:  2018-10-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.